Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 01, 2025

Get In Touch

Morphine Promising Treatment To Palliate Cough In IPF Patients: PACIFY COUGH Study Cardiology and CTVS

Morphine Promising Treatment To Palliate Cough In IPF Patients: PACIFY COUGH Study

  • 06 August 2025
  • 2 months ago

Systolic BP Variability Powerful Determinant Of CV Outcome; Amlodipine May Render Long-Term Benefit: Confirms ASCOT Trial Cardiology and CTVS

Systolic BP Variability Powerful Determinant Of CV Outcome; Amlodipine May Render Long-Term Benefit: Confirms ASCOT Trial

  • 06 August 2025
  • 2 months ago

Treatment With DPP-4i Versus Sulphonylureas Yield Similar MACE Risk In Type 2 Diabetics: Study Diabetes and Endocrinology

Treatment With DPP-4i Versus Sulphonylureas Yield Similar MACE Risk In Type 2 Diabetics: Study

  • 06 August 2025
  • 2 months ago

Patients With Severe Infections At Increased Risk Of Major CV Events After Hospitalization Cardiology and CTVS

Patients With Severe Infections At Increased Risk Of Major CV Events After Hospitalization

  • 06 August 2025
  • 2 months ago

New Fatal Vasculitis In LVADs Recipients: Case Series Reported In JACC Cardiology and CTVS

New Fatal Vasculitis In LVADs Recipients: Case Series Reported In JACC

  • 06 August 2025
  • 2 months ago

Sacubitril/Valsartan Exhibits CV And Kidney Protective Benefits Across The Spectrum Of Kidney Risk In Heart Failure Patients: JACC Nephrology

Sacubitril/Valsartan Exhibits CV And Kidney Protective Benefits Across The Spectrum Of Kidney Risk In Heart Failure Patients: JACC

  • 06 August 2025
  • 2 months ago

Use Of Cusp-Overlapping Projection In TAVR Reduces Rate Of Permanent Pacemaker Implantation: JACC Cardiology and CTVS

Use Of Cusp-Overlapping Projection In TAVR Reduces Rate Of Permanent Pacemaker Implantation: JACC

  • 06 August 2025
  • 2 months ago

RenalGuard Ineffective In Preventing High-Risk Contrast-Induced Nephropathy Nephrology

RenalGuard Ineffective In Preventing High-Risk Contrast-Induced Nephropathy

  • 06 August 2025
  • 2 months ago

DOACs Safer Than Warfarin Analogues For TAVR Patients, JACC Study. Cardiology and CTVS

DOACs Safer Than Warfarin Analogues For TAVR Patients, JACC Study.

  • 06 August 2025
  • 2 months ago

Rare Case Of Mycotic Aneurysm Of Brachial Artery In Patient With Aplastic Anemia Cardiology and CTVS

Rare Case Of Mycotic Aneurysm Of Brachial Artery In Patient With Aplastic Anemia

  • 06 August 2025
  • 2 months ago

Recent News

Global review links common viral infections to hig...

  • 01 November, 2025

Lower ketone levels and improved exercise capacity...

  • 01 November, 2025

Citrus Flavonoids effective nutritional adjunct to...

  • 01 November, 2025

Daily kimchi intake linked to reduced BMI and bell...

  • 01 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.